Final Overall Survival Data from KEYNOTE-006 To Be Presented at ASCO; KEYTRUDA, the First Anti-PD-1 Monotherapy to Demonstrate Overall Survival...
Read moreGlaxoSmithKline and Innoviva, Inc announced results from data presented at the American Thoracic Society (ATS) 2016 International Conference investigating the...
Read more• 14 avelumab abstracts at ASCO 2016 highlight significant progress being made by the collaboration between Merck KGaA, ...
Read morePfizer announced results from the second phase of its global RA surveys, which assessed the relationship between physician-patient communication and...
Read more• Ho Chi Minh City Communities for Healthy Hearts Program is the second innovative healthcare model for hypertension ...
Read moreGSK presented new data for its meningococcal group B vaccine, Bexsero®,1 comparing safety...
Read moreSwedish Orphan Biovitrum AB and Biogen announced that the European Commission (EC) has approved Alprolix® (rFIXFc), their extended half-life therapy,...
Read moreSwedish Orphan Biovitrum AB and Biogen announced that the European Commission (EC) has approved Alprolix® (rFIXFc), their extended half-life therapy,...
Read moreAbbVie will participate in the UBS Global Healthcare Conference on Monday, May 23, 2016. Bill Chase, executive vice president and...
Read moreMerck, a leading science and technology company, will exhibit a new range of products and solutions at Analytica 2016, the...
Read more
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
